Background We observe changes of the main lymphocyte subsets (CD16+ CD56, CD19,
CD3, CD4, and CD8) in COVID-19-infected patients and explore whether the changes are …

Background The 2019 novel coronavirus (COVID-19) emerged in Wuhan in December 2019
and has since rapidly spread across China and to the globe. This virus shows unusually …

The spectrum of coronavirus disease 2019 (COVID-19) severity, related to cellular immune
functions, has not been fully clarified yet. Therefore, this study aimed to investigate the …

Background: Although the pathophysiology of coronavirus disease 2019 (COVID-19) is not
clearly defined, among the proposed mechanisms, immune system dysfunction is more …

To discover immune factors that can predict the progression of COVID-19, we evaluated
circulating immune cells and plasma cytokines in COVID-19 patients. We found that T cells …

The velocity of the COVID-19 pandemic spread and the variable severity of the disease
course has forced scientists to search for potential predictors of the disease outcome. We …

Background In December 2019, an outbreak of coronavirus disease 2019 (COVID-19),
caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

To investigate the inflammatory factors and lymphocyte subsets which play an important role
in the course of severe coronavirus disease 2019 (COVID‐19). A total of 27 patients with …

This single-center, retrospective study aimed to explore the immune characteristics of
COVID-19 and biomarkers to predict the severity of this disease. Patients infected with SARS …

Objective To investigate the characteristics and predictive roles of lymphocyte subsets in
COVID-19 patients. Method We evaluated lymphocyte subsets and other clinical features of …